NCT04918368

Brief Summary

Lack of sleep and poor sleep quality in pregnant women are associated with maternal depression and cognitive-sensual irregularities. These irregularities were reported worsening women's life quality and even increasing suicide ideation. It is also associated with obstetrical complications such as fetal growth deficiency, preterm birth, prolonged labor, preeclampsia and increased abdominal delivery frequency.Vitamin D also may affect the sleep indirectly through the cases with nonspecific pains. It was reported that vitamin D levels are correlated with sleep disorders such as obstructive sleep apnea and restless legs syndrome. The primary purpose of this study is to examine sleep disorders and vitamin D levels in pregnant women, and also, secondarily, vitamin D - anxiety and sleep disorders - anxiety relations were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 17, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 8, 2021

Completed
Last Updated

August 25, 2021

Status Verified

April 1, 2018

Enrollment Period

1.3 years

First QC Date

April 17, 2021

Last Update Submit

August 23, 2021

Conditions

Keywords

anxietyPregnancy,Sleep Wake DisordersVitamin D

Outcome Measures

Primary Outcomes (2)

  • Health Initiative Sleeplessness Scale (WHISS)

    Women's Health Initiative Sleeplessness Scale (WHISS) was used to assess the sleep status of pregnant women. In this scale consisting of five questions, first four questions focus on the period of time when sleeplessness started, status of not being able to continue the sleep and waking up early in the morning, while the last one focusses to determine the sleep quality. Scores of the scale range between 0 - 20. A score equal and above 10 means a sleeplessness problem. An increase in score means intensifying the sleeplessness symptoms.

    Through study completion, an average of 1 year

  • State Anxiety Scale (SAS)

    In anxiety screening of pregnant women, State Anxiety Scale (SAS) was used. Scores of the scale including twenty questions range between min. 20 and max. 80. Higher scores mean higher anxiety.

    Through study completion, an average of 1 year

Study Arms (1)

Pregnant women between 18-45 years old, being in second and third trimester of a singleton pregnancy

Behavioral: Behavioral scales were used

Interventions

Women's Health Initiative Sleeplessness Scale (WHISS) and State Anxiety Scale (SAS), were applied.

Pregnant women between 18-45 years old, being in second and third trimester of a singleton pregnancy

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

225 pregnant women who are in second or third trimester of pregnancy

You may qualify if:

  • singletone pregnant women
  • second and third trimester pregnant women

You may not qualify if:

  • psychiatric disorder
  • sleep disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatma Ketenci Gencer

Istanbul, 34255, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sleep Wake DisordersVitamin D DeficiencyAnxiety Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

April 17, 2021

First Posted

June 8, 2021

Study Start

August 20, 2017

Primary Completion

December 25, 2018

Study Completion

March 15, 2019

Last Updated

August 25, 2021

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations